223 related articles for article (PubMed ID: 25714010)
21. MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1.
Zhao J; Li D; Fang L
Biomed Pharmacother; 2019 Jul; 115():108947. PubMed ID: 31078043
[TBL] [Abstract][Full Text] [Related]
22. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system.
Bagheri-Yarmand R; Mazumdar A; Sahin AA; Kumar R
Int J Cancer; 2006 Jun; 118(11):2703-10. PubMed ID: 16381000
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of p21-activated kinase 6 inhibits prostate cancer growth and enhances chemosensitivity to docetaxel.
Wen X; Li X; Liao B; Liu Y; Wu J; Yuan X; Ouyang B; Sun Q; Gao X
Urology; 2009 Jun; 73(6):1407-11. PubMed ID: 19362342
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of Rac1/PAK1/LIMK1/cofilin signaling pathway in colon cancer SW620 cells treated with Chlorin e6 photodynamic therapy.
Wufuer R; Ma HX; Luo MY; Xu KY; Kang L
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102143. PubMed ID: 33307230
[TBL] [Abstract][Full Text] [Related]
26. LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target.
Kang X; Li W; Liu W; Liang H; Deng J; Wong CC; Zhao S; Kang W; To KF; Chiu PWY; Wang G; Yu J; Ng EKW
Oncogene; 2021 May; 40(19):3422-3433. PubMed ID: 33883692
[TBL] [Abstract][Full Text] [Related]
27. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
28. MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.
Zhou J; Liu R; Luo C; Zhou X; Xia K; Chen X; Zhou M; Zou Q; Cao P; Cao K
Cancer Biol Ther; 2014 Oct; 15(10):1340-9. PubMed ID: 25019203
[TBL] [Abstract][Full Text] [Related]
29. A role for LIM kinase in cancer invasion.
Yoshioka K; Foletta V; Bernard O; Itoh K
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7247-52. PubMed ID: 12777619
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of miR-93 and inhibition of LIMK1 improve ventricular remodeling and alleviate cardiac dysfunction in rats with chronic heart failure by inhibiting RhoA/ROCK signaling pathway activation.
Su Q; Zhang P; Yu D; Wu Z; Li D; Shen F; Liao P; Yin G
Aging (Albany NY); 2019 Sep; 11(18):7570-7586. PubMed ID: 31541994
[TBL] [Abstract][Full Text] [Related]
31. The pre-GAP-related domain of neurofibromin regulates cell migration through the LIM kinase/cofilin pathway.
Starinsky-Elbaz S; Faigenbloom L; Friedman E; Stein R; Kloog Y
Mol Cell Neurosci; 2009 Dec; 42(4):278-87. PubMed ID: 19666124
[TBL] [Abstract][Full Text] [Related]
32. Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.
Siu MK; Abou-Kheir W; Yin JJ; Chang YS; Barrett B; Suau F; Casey O; Chen WY; Fang L; Hynes P; Hsieh YY; Liu YN; Huang J; Kelly K
Oncotarget; 2014 Jun; 5(11):3770-84. PubMed ID: 25004126
[TBL] [Abstract][Full Text] [Related]
33. Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer.
Zhao CC; Zhan MN; Liu WT; Jiao Y; Zhang YY; Lei Y; Zhang TT; Zhang CJ; Du YY; Gu KS; Wei W
Cancer Lett; 2020 Nov; 493():120-127. PubMed ID: 32829006
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA‑328 directly targets p21‑activated protein kinase 6 inhibiting prostate cancer proliferation and enhancing docetaxel sensitivity.
Liu C; Zhang L; Huang Y; Lu K; Tao T; Chen S; Zhang X; Guan H; Chen M; Xu B
Mol Med Rep; 2015 Nov; 12(5):7389-95. PubMed ID: 26459798
[TBL] [Abstract][Full Text] [Related]
35. P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.
Goc A; Al-Azayzih A; Abdalla M; Al-Husein B; Kavuri S; Lee J; Moses K; Somanath PR
J Biol Chem; 2013 Feb; 288(5):3025-35. PubMed ID: 23258534
[TBL] [Abstract][Full Text] [Related]
36. p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2).
Liu T; Li Y; Gu H; Zhu G; Li J; Cao L; Li F
J Biol Chem; 2013 Feb; 288(5):3359-69. PubMed ID: 23132866
[TBL] [Abstract][Full Text] [Related]
37. LIM kinase 1 is required for insulin‑dependent cell growth of osteosarcoma cell lines.
Zhang HS; Zhao JW; Wang H; Zhang HY; Ji QY; Meng LJ; Xing FJ; Yang ST; Wang Y
Mol Med Rep; 2014 Jan; 9(1):103-8. PubMed ID: 24247826
[TBL] [Abstract][Full Text] [Related]
38. DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1.
Li X; Ke Q; Li Y; Liu F; Zhu G; Li F
Int J Biochem Cell Biol; 2010 Jan; 42(1):70-9. PubMed ID: 19778628
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial PAK6 inhibits prostate cancer cell apoptosis
Li T; Li Y; Liu T; Hu B; Li J; Liu C; Liu T; Li F
Theranostics; 2020; 10(6):2571-2586. PubMed ID: 32194820
[No Abstract] [Full Text] [Related]
40. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B
Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
